We examined a possible role for the adhesion molecules
LFA-1 and
ICAM-1 in localizing central nervous system non-Hodgkin's
lymphomas (CNS-NHLs) to the brain. Fresh frozen sections from 12 monoclonal CNS NHLs (11 primary, one secondary) were stained with
monoclonal antibodies to
LFA-1 alpha chain (CD11a), beta chain (CD18) and,
ICAM-1 (CD54). Additional staining made use of rat
monoclonal antibodies to the human and mouse high endothelial venule
antigens HECA 452 and
MECA 79 and mouse
ICAM-1. The expression of these same molecules was also studied in mice with
severe combined immunodeficiency (SCID) mice, bearing intracranial human lymphoblastoid cells. Eleven of the CNS-NHL
tumors expressed
LFA-1 alpha (one strongly, one intermediate, nine weakly). Nine of the
tumors weakly expressed
LFA-1 beta.. Nine of twelve
tumors weakly expressed
ICAM-1. In six of seven
tumors definite blood vessels stained for
ICAM-1. Non-
tumor brain from two patients and non-
tumor cerebral blood vessels showed no staining with CD11a, CD18 or CD54
antibodies. Strong expression of LFA-alpha and LFA-beta as well as
ICAM-1 was noted in human lymphoblastoid cells (LCLs)/SCID mouse CNS
lymphomas.
Tumor blood vessels in these mice stained for mouse
ICAM-1. Normal SCID mouse brains showed no staining with CD11a, CD18, CD54 or mouse
ICAM-1 antibodies. Human, human/mouse CNS
lymphomas, normal human, and mouse brains showed no staining with either HECA 452 or
MECA 79.(ABSTRACT TRUNCATED AT 250 WORDS)